Vycor Medical (VYCO) Total Non-Current Liabilities (2014 - 2026)
Vycor Medical's (VYCO) quarterly Total Non-Current Liabilities came in at $1.2 million in Q1 2026, down 7.97% year-on-year from $1.4 million in Q1 2025, and down 0.72% on a QoQ basis from $1.3 million in Q4 2025.
Vycor Medical (VYCO) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 9 years of Total Non-Current Liabilities data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 7.97% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 7.97% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 9.4% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $1.2 million, down from $1.3 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for VYCO reached as high as $1.4 million in Q3 2024 and fell as low as $145429.0 in Q1 2023.
- Historically, Total Non-Current Liabilities has averaged $977282.3 across 5 years, with a median of $1.3 million in 2025.
- Across the five-year window, Total Non-Current Liabilities decreased 24.7% in 2022 and soared 830.6% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $146253.0 in 2022, then jumped by 828.73% to $1.4 million in 2023, then rose by 2.3% to $1.4 million in 2024, then decreased by 9.4% to $1.3 million in 2025, then fell by 0.72% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 145,429.00 |
| Dec 31, 2022 | 146,253.00 |
| Sep 30, 2022 | 147,070.00 |
| Jun 30, 2022 | 153,900.00 |
| Mar 31, 2022 | 167,060.00 |
| Dec 31, 2021 | 180,580.00 |
| Sep 30, 2021 | 192,625.00 |
| Jun 30, 2021 | 204,395.00 |